4DMedical Ltd.ASX: 4DX

Former ResMed CFO Brett Sandercock joins 4DMedical Board

· Issued by 4DMedical Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

4DMedical Ltd. announces the appointment of Brett Sandercock as an independent Non-Executive Director, effective immediately. Brett Sandercock, former CFO of ResMed, will chair the Audit and Risk Committee and join the Remuneration and Nomination Committee. His extensive experience in finance leadership within global healthcare technology is expected to enhance the Board's capabilities. The Board considers him an independent director and he will stand for election at the next Annual General Meeting.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX announcement ASX:4DX Former ResMed CFO Brett Sandercock joins 4DMedical Board Melbourne, Australia, 16 November 2026: 4DMedical Limited (“ASX:4DX”, “4DMedical” or the “Company”), a global leader in respiratory imaging technology, today announces the appointment of Brett Sandercock...

4DMedical Ltd. on 6ix

Earlier from 4DMedical

All 4DMedical news releases